Skip to content

Evaluation of a New mHealth Tympanometer

A Pilot Study to Assess Performance of a New Low-Cost Mobile Health Based Prototype Tympanometer

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05666505
Enrollment
39
Registered
2022-12-27
Start date
2024-10-30
Completion date
2024-12-10
Last updated
2026-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hearing Loss

Keywords

Rural, Screening, Tympanometer, Mobile health (mHealth), Otitis media, ML Algorithm

Brief summary

Children in rural and underserved communities experience a disproportionately high burden of infection-related hearing loss, which is often preventable with timely identification and follow-up care. A tympanometer is a device that evaluates the health of the middle ear but is often not used in screening programs due to barriers of high cost and need for trained professionals such as audiologists to use the device. To address these barriers, a low cost, lay friendly, mobile health (mHealth) prototype tympanometer has been developed. In addition, a machine learning (ML) algorithm has been designed to guide lay users to interpret tympanometer results, overcoming the need for audiologists. Broad implementation of the lay friendly tympanometer and ML algorithm will transform screening in areas where prevalence of infection-related hearing loss is high, and access to specialty care is limited. In this study the prototype mHealth tympanometer will be evaluated against commercial tympanometry. It will be used by audiologists, an essential step before testing the performance of the device with lay users. Approximately 20 adult patients and 10 pediatric patients with various middle ear pathologies will be enrolled in the study, with the goal of obtaining 60 ears with data from both the prototype and commercial tympanometers. Audiologists will obtain tympanometry measurements on both ears of each participant and interpret the results, first with the prototype device and then with the commercial tympanometer that is typically used during a clinical evaluation. Tympanometry interpretation will include classification into one of 3 categories (Type A, B, or C). Agreement in results between the prototype and commercial devices will be assessed. Agreement between audiologist interpretations and the ML algorithm from the prototype mHealth tympanometer will be assessed.

Interventions

DEVICEPrototype mHealth tympanometer

The prototype mHealth tympanometer functions similarly to a commercial tympanometer. Tympanometers are designed to assess middle ear function by measuring changes in acoustic tone related to subtle movement of the tympanic membrane from an applied air pressure sweep. An audiologist will review the tympanogram tracings and classify results as Type A, B, or C.

DEVICEStandard of care commercial tympanometer

A commercial tympanometer routinely used as part of standard of care will be used as the comparison. Tympanometers are designed to assess middle ear function by measuring changes in acoustic tone related to subtle movement of the tympanic membrane from an applied air pressure sweep. An audiologist will review the tympanogram tracings and classify results as Type A, B, or C.

Sponsors

University of Arkansas
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SCREENING
Masking
NONE

Intervention model description

Each participant will be first tested with prototype mHealth tympanometer, and then with a commercial tympanometer routinely used in clinical settings.

Eligibility

Sex/Gender
ALL
Age
1 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Presenting to Audiology Clinic for evaluation, where tympanometry is warranted for testing at the discretion of the audiologist * Presence of various middle ear health states/pathologies that result in Type A, B, C tympanograms * English-speaking

Exclusion criteria

* Children or adults with cognitive disabilities * Unable to provide consent/assent * Individuals who are unable to sit still * Any other condition that in the opinion of the investigator, might interfere with the safe conduct of the study or place the participant at increased risk

Design outcomes

Primary

MeasureTime frameDescription
Classification Agreement Between Prototype mHealth Tympanometer and Commercial TympanometerSame day as participant visit, up to 10 minutesAudiologist will test each ear of the participant first with the prototype device, interpret the results into one of the three tympanogram categories (Type A/B/C) and record the results. The procedure will be repeated with a commercial device. Agreement between the two devices with respect to the classification categories will be assessed.
Classification Agreement Between Audiologist and ML Algorithm Interpretations Using Prototype mHealth TympanometerSame day as participant visit, up to 10 minutesTympanogram results collected using the prototype mHealth tympanometer will be run through the ML algorithm for classification into Type A/B/C. Agreement between the audiologist and the ML algorithm with respect to the classification categories will be assessed.

Participant flow

Participants by arm

ArmCount
Tympanometer Comparison
Both ears of each participant will be tested first with the prototype mHealth tympanometer followed by standard of care commercial tympanometer
38
Total38

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyWithdrawn due to caregiver consent obtained from non-legal guardian1

Baseline characteristics

CharacteristicTympanometer Comparison
Age, Categorical
<=18 years
16 Participants
Age, Categorical
>=65 years
11 Participants
Age, Categorical
Between 18 and 65 years
11 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
Race (NIH/OMB)
Asian
0 Participants
Race (NIH/OMB)
Black or African American
7 Participants
Race (NIH/OMB)
More than one race
0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
5 Participants
Race (NIH/OMB)
White
26 Participants
Sex: Female, Male
Female
24 Participants
Sex: Female, Male
Male
14 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 390 / 39
other
Total, other adverse events
0 / 390 / 39
serious
Total, serious adverse events
0 / 390 / 39

Outcome results

Primary

Classification Agreement Between Audiologist and ML Algorithm Interpretations Using Prototype mHealth Tympanometer

Tympanogram results collected using the prototype mHealth tympanometer will be run through the ML algorithm for classification into Type A/B/C. Agreement between the audiologist and the ML algorithm with respect to the classification categories will be assessed.

Time frame: Same day as participant visit, up to 10 minutes

Population: The analytic sample is limited to ear-level results that produced a classification result of A/B/C for both devices. Ears were not included in the main analysis if data from one device or both devices were missing for that ear.

ArmMeasureValue (NUMBER)
Tympanometer ComparisonClassification Agreement Between Audiologist and ML Algorithm Interpretations Using Prototype mHealth Tympanometer0.81 Kappa-statistic (Agreement)
Primary

Classification Agreement Between Prototype mHealth Tympanometer and Commercial Tympanometer

Audiologist will test each ear of the participant first with the prototype device, interpret the results into one of the three tympanogram categories (Type A/B/C) and record the results. The procedure will be repeated with a commercial device. Agreement between the two devices with respect to the classification categories will be assessed.

Time frame: Same day as participant visit, up to 10 minutes

Population: The analytic sample is limited to ear-level results that produced a classification result of A/B/C for both devices. Ears were not included in the main analysis if data from one device or both devices were missing for that ear.

ArmMeasureValue (NUMBER)
Tympanometer ComparisonClassification Agreement Between Prototype mHealth Tympanometer and Commercial Tympanometer93.33 Percent Agreement

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026